LIVN
LivaNova Plc
NASDAQ · Healthcare · Medical - Devices · GB
$78.14
+0.72%Forward multiples
Based on analyst estimates
- P/E forward
- 17.25x
- P/E 2026E
- 18.01x
- P/E 2027E
- 16.76x
- P/E 2028E
- 14.99x
- P/S forward
- 2.69x
Trailing multiples
Trailing twelve months
- P/E TTM
- 22.65x
- PEG TTM
- 0.73x
- Price / book
- 3.25x
- Price / sales
- 2.93x
- Price / cash flow
- 17.27x
Enterprise value
- Enterprise value
- $4.1B
- EV / sales
- 2.81x
- EV / EBITDA
- 19.12x
- EV / EBIT
- 20.88x
- Market cap
- $4.3B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026